300 related articles for article (PubMed ID: 6465114)
1. Patient selection and survival after peritoneovenous shunting for nonmalignant ascites.
Smith RE; Nostrant TT; Eckhauser FE; Wilson JP; Knol JA; Strodel WE
Am J Gastroenterol; 1984 Aug; 79(8):659-62. PubMed ID: 6465114
[TBL] [Abstract][Full Text] [Related]
2. [Peritoneovenous shunting in intractable ascites of cirrhosis. Results of a prospective study on improving prognostic factors].
Hillaire S; Labianca M; Smadja C; Grange D; Franco D
Gastroenterol Clin Biol; 1988 Oct; 12(10):681-6. PubMed ID: 3220223
[TBL] [Abstract][Full Text] [Related]
3. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal venous shunting for ascites: a 15-year perspective.
Hyde GL; Dillon M; Bivins BA
Am Surg; 1982 Mar; 48(3):123-7. PubMed ID: 7073133
[TBL] [Abstract][Full Text] [Related]
5. Peritoneovenous shunts: predictive factors of early treatment failure.
Gleysteen JJ; Klamer TW
Am J Gastroenterol; 1984 Aug; 79(8):654-8. PubMed ID: 6465113
[TBL] [Abstract][Full Text] [Related]
6. Peritoneovenous shunting of intractable ascites in patients with cirrhosis: improving results and predictive factors of failure.
Hillaire S; Labianca M; Borgonovo G; Smadja C; Grange D; Franco D
Surgery; 1993 Apr; 113(4):373-9. PubMed ID: 8456392
[TBL] [Abstract][Full Text] [Related]
7. Poor outcome from peritoneovenous shunts for refractory ascites.
Scholz DG; Nagorney DM; Lindor KD
Am J Gastroenterol; 1989 May; 84(5):540-3. PubMed ID: 2719011
[TBL] [Abstract][Full Text] [Related]
8. [12-year experience with continuous peritoneovenous shunt in the treatment of therapy-resistant ascites and hepatorenal failure: benefits and pitfalls].
Kreuzer W
Wien Klin Wochenschr; 1989 Jan; 101(2):87-91. PubMed ID: 2916345
[TBL] [Abstract][Full Text] [Related]
9. Peritoneovenous shunting for cirrhotic versus malignant ascites.
Kostroff KM; Ross DW; Davis JM
Surg Gynecol Obstet; 1985 Sep; 161(3):204-8. PubMed ID: 2412302
[TBL] [Abstract][Full Text] [Related]
10. Peritoneovenous shunting for intractable ascites.
Tyden G; Samnegård H; Thulin L
Acta Chir Scand; 1982; 148(7):597-600. PubMed ID: 7168289
[TBL] [Abstract][Full Text] [Related]
11. Failure of LeVeen shunting in refractory ascites--a view from the other side.
Grischkan DM; Cooperman AM; Hermann RE; Carey WD; Ferguson DR; Cook SA
Surgery; 1981 Mar; 89(3):304-8. PubMed ID: 7466618
[TBL] [Abstract][Full Text] [Related]
12. The peritoneovenous shunt: expectations and reality.
Moskovitz M
Am J Gastroenterol; 1990 Aug; 85(8):917-29. PubMed ID: 2197858
[TBL] [Abstract][Full Text] [Related]
13. Peritoneovenous shunting for intractable ascites.
Gullstrand P; Alwmark A; Börjesson B; Joelsson B; Bengmark S
Scand J Gastroenterol; 1982 Nov; 17(8):1009-12. PubMed ID: 7167735
[TBL] [Abstract][Full Text] [Related]
14. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
15. Peritoneovenous shunting for malignant ascites.
Wickremesekera SK; Stubbs RS
N Z Med J; 1997 Feb; 110(1037):33-5. PubMed ID: 9066565
[TBL] [Abstract][Full Text] [Related]
16. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites.
Stanley MM; Ochi S; Lee KK; Nemchausky BA; Greenlee HB; Allen JI; Allen MJ; Baum RA; Gadacz TR; Camara DS
N Engl J Med; 1989 Dec; 321(24):1632-8. PubMed ID: 2586565
[TBL] [Abstract][Full Text] [Related]
17. Short- and long-term effectiveness, morbidity, and mortality of peritoneovenous shunt inserted to treat massive refractory ascites of nephrogenic origin analysis of 14 cases.
Holm A; Rutsky EA; Aldrete JS
Am Surg; 1989 Nov; 55(11):645-52. PubMed ID: 2479308
[TBL] [Abstract][Full Text] [Related]
18. Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt.
Guardiola J; Xiol X; Escribá JM; Castellví JM; Castellote J; Baliellas C; Rafecas A; Casais LA
Am J Gastroenterol; 1995 Dec; 90(12):2097-102. PubMed ID: 8540495
[TBL] [Abstract][Full Text] [Related]
19. [The Leveen shunt in refractory ascites and hepatorenal syndrome. Review of the literature, 10 years later].
Lheureux P; Gelin M
Acta Gastroenterol Belg; 1984; 47(5):476-83. PubMed ID: 6534047
[No Abstract] [Full Text] [Related]
20. [Treatment of hemorrhagic syndrome caused by peritoneovenous shunt with a flow regulation device].
Violi V; Montanari M; Roncoroni L
G Chir; 1990; 11(7-8):413-5. PubMed ID: 2282274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
